Pine Tree Equity Recapitalizes Summit Health Pharmacy

/in /by

Pine Tree Equity IV, LP (“Pine Tree Equity”), a private equity firm based in Miami, FL, is pleased to announce that it has recapitalized Summit Health Pharmacy, LLC (“Summit” or the “Company”) in December 2021. The Company, founded in 1995 and headquartered in Brookhaven, PA, is a leading provider of pharmacy compounding services, with a focus on rare pediatric metabolic medications. Summit operates a 503A pharmacy that produces prescriptions customized for, and specific to, individual patients. Summit marks Pine Tree Equity’s 99th investment since inception in 2007 (i.e., 30 platform and 69 add-on acquisitions).

SPS Health Announces Growth Investment from Nautic Partners

/in , /by

SPS Health, a leading value-based care solutions provider serving post-acute pharmacies and pharmacy benefit managers, announced a strategic growth investment from Nautic Partners (“Nautic”). Nautic Partners is a private equity firm with deep healthcare experience and invested in SPS out of its tenth fund, which has over $3 billion of committed capital. This partnership will support SPS Health’s further investment in innovative technology and clinical and operational solutions supporting its pharmacy and PBM clients.

TPG Invests in AnovoRx

/in /by

TPG Growth, the middle market and growth equity platform of alternative asset firm TPG, today announced that it made a significant minority investment in AnovoRx Holdings, Inc. (“Anovo”), a leading provider of specialty pharmacy services and customized treatment and support programs that address the unique needs of patients with certain complex and chronic diseases.

Private Equity Ready to Swoop as Walgreens Mulls Sale of Boots

/in /by

Two of the world’s biggest buyout firms, Bain Capital and CVC Capital Partners, are understood to be lining up a multi-billion-dollar takeover of Boots, the U.K.’s largest drugstore chain. Currently part of the U.S./U.K. mega-group Walgreens Boots Alliance (WBA), an auction of Boots appears increasingly likely this spring, which would represent one of the biggest U.K. retail deals for years. The American owner of Boots received a takeover approach from Bain Capital more than two months ago, prompting consideration of a sale of the U.K. high street chain, according to The Times.

Pack4U Acquires Leading Pharmacy Technology Company Catalyst Healthcare

/in , /by

Pack4U, a connected health services company, acquires long-time technology partner Catalyst Healthcare whose patented AdhereNet® platform links pharmacists, patients, and care teams to effectively manage drug complexity and improve medication adherence. Pack4U provides in-home and virtual services that connect patients with pharmacists for oversight, medication delivery, remote monitoring, and care coordination.

CareDx Expands Its Medication Adherence Services with the Acquisition of The Transplant Pharmacy

/in /by

CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, announced Wednesday that it has acquired The Transplant Pharmacy, a transplant focused pharmacy located in Flowood, Mississippi, to expand its medication management and adherence services. The Transplant Pharmacy provides individualized transplant pharmacy services for patients at multiple transplant centers located throughout the United States.

WindRose Health Investors Invests in Terrapin Pharmacy

/in /by

WindRose Health Investors, LLC (“WindRose”), the New York-based healthcare private equity firm, announced that it has completed the recapitalization of Terrapin Pharmacy LLC (“Terrapin” or the “Company”), a leading specialized pharmacy offering high-touch, value-added distribution and medication adherence services and technology. The Company primarily serves patients with severe and persistent mental illness (SPMI), intellectual and developmental disabilities (IDD), and substance abuse disorders.

Omnicell Acquires MarkeTouch Media

/in , /by

Omnicell, Inc. (Nasdaq:OMCL), a leading provider of medication management solutions and adherence tools for health systems and pharmacies, today announced it has acquired pharmacy software solutions provider MarkeTouch Media, LLC for total aggregate cash consideration of $82 million, subject to customary adjustments. The acquisition is expected to expand the footprint of Omnicell’s EnlivenHealthTM division across the retail pharmacy sector, while enhancing potential growth opportunities in new market segments like specialty pharmacy and pharmacy benefits management.

Omnicell Completes Acquisition of ReCept

/in /by

Omnicell, Inc. (Nasdaq:OMCL), a leading provider of medication management solutions and adherence tools for health systems and pharmacies, has completed the previously announced acquisition of ReCept Holdings, Inc. The addition of ReCept’s specialty pharmacy management services for health systems, provider groups, and federally qualified health centers (FQHCs) expands Omnicell’s Advanced Services portfolio to address the growing and complex specialty pharmacy market.

McKesson Corporation Enters Agreement to Sell Its Austrian Business to Quadrifolia Management GmbH

/in /by

McKesson Corporation (NYSE: MCK) announced that it has entered into an agreement to sell its Austrian business to Quadrifolia Management GmbH (“Quadrifolia”). The transaction includes the sale of McKesson Austria’s Herba Chemosan Apotheker-AG, together with Sanova Pharma GesmbH. Quadrifolia will be conducting a management buyout which will see the existing management of the Austrian business buy all of the Herba Chemosan Apotheker-AG and Sanova Pharma GesmbH, backed by Invest AG.